On the public citation graph

A curated and standardized adverse drug event resource to accelerate drug safety research

0 signed · 281 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/pds.668openalex-snapshot
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
inferredcites →https://doi.org/10.1002/pds.677openalex-snapshot
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
inferredcites →https://doi.org/10.1002/sim.5925openalex-snapshot
Interpreting observational studies: why empirical calibration is needed to correct p‐values
inferredcites →https://doi.org/10.1007/978-3-319-25010-6_18openalex-snapshot
Provenance-Centered Dataset of Drug-Drug Interactions
inferredcites →https://doi.org/10.1007/s40264-013-0097-8openalex-snapshot
Defining a Reference Set to Support Methodological Research in Drug Safety
inferredcites →https://doi.org/10.1007/s40264-014-0155-xopenalex-snapshot
Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter
inferredcites →https://doi.org/10.1007/s40264-014-0180-9openalex-snapshot
Safety Signal Detection: The Relevance of Literature Review
inferredcites →https://doi.org/10.1007/s40264-014-0189-0openalex-snapshot
Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest
inferredcites →https://doi.org/10.1007/s40264-014-0218-zopenalex-snapshot
Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art
inferredcites →https://doi.org/10.1007/s40264-015-0352-2openalex-snapshot
Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records
inferredcites →https://doi.org/10.1016/j.jbi.2015.02.004openalex-snapshot
Utilizing social media data for pharmacovigilance: A review
inferredcites →https://doi.org/10.1016/j.jbi.2015.04.006openalex-snapshot
Toward a complete dataset of drug–drug interaction information from publicly available sources
inferredcites →https://doi.org/10.1016/j.jbi.2015.08.022openalex-snapshot
Leveraging MEDLINE indexing for pharmacovigilance – Inherent limitations and mitigation strategies
inferredcites →https://doi.org/10.1016/s1086-5802(16)31229-3openalex-snapshot
Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model
inferredcites →https://doi.org/10.1038/clpt.2008.274openalex-snapshot
Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events
inferredcites →https://doi.org/10.1038/clpt.2011.55openalex-snapshot
Pharmacological Mechanism-Based Drug Safety Assessment and Prediction
inferredcites →https://doi.org/10.1038/clpt.2012.50openalex-snapshot
Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis
inferredcites →https://doi.org/10.1038/clpt.2012.54openalex-snapshot
Detection of Pharmacovigilance-Related Adverse Events Using Electronic Health Records and Automated Methods
inferredcites →https://doi.org/10.1038/clpt.2013.47openalex-snapshot
Pharmacovigilance Using Clinical Notes
inferredcites →https://doi.org/10.1038/clpt.2013.60openalex-snapshot
Advancing the Science of Pharmacovigilance
inferredcites →https://doi.org/10.1038/clpt.2014.77openalex-snapshot
Toward Enhanced Pharmacovigilance Using Patient-Generated Data on the Internet
inferredcites →https://doi.org/10.1093/jamia/ocu041openalex-snapshot
Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features
inferredcites →https://doi.org/10.1093/jamia/ocv102openalex-snapshot
A method for systematic discovery of adverse drug events from clinical notes
inferredcites →https://doi.org/10.1126/scitranslmed.3003377openalex-snapshot
Data-Driven Prediction of Drug Effects and Interactions
inferredcites →https://doi.org/10.1136/amiajnl-2011-000096openalex-snapshot
Using information mining of the medical literature to improve drug safety
inferredcites →https://doi.org/10.1136/amiajnl-2011-000214openalex-snapshot
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports
inferredcites →https://doi.org/10.1136/amiajnl-2011-000417openalex-snapshot
Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis
inferredcites →https://doi.org/10.1136/amiajnl-2012-001083openalex-snapshot
Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU–ADR project
inferredcites →https://doi.org/10.1136/amiajnl-2012-001482openalex-snapshot
Web-scale pharmacovigilance: listening to signals from the crowd
inferredcites →https://doi.org/10.1136/amiajnl-2013-001612openalex-snapshot
Mining clinical text for signals of adverse drug-drug interactions
inferredcites →https://doi.org/10.1142/9789814644730_0030openalex-snapshot
ANALYZING SEARCH BEHAVIOR OF HEALTHCARE PROFESSIONALS FOR DRUG SAFETY SURVEILLANCE
inferredcites →https://doi.org/10.1186/2041-1480-3-s1-s5openalex-snapshot
Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes
inferredcites →https://doi.org/10.1186/2041-1480-5-36openalex-snapshot
Standardizing adverse drug event reporting data
inferredcites →https://doi.org/10.2196/jmir.2614openalex-snapshot
Postmarket Drug Surveillance Without Trial Costs: Discovery of Adverse Drug Reactions Through Large-Scale Analysis of Web Search Queries
inferredcites →https://doi.org/10.3233/978-1-61499-564-7-574openalex-snapshot
Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers
inferredcites →https://doi.org/10.4103/0253-7613.56068openalex-snapshot
Therapeutic class-specific signal detection of bradycardia associated with propranolol hydrochloride
inferredcites →https://doi.org/10.5061/dryad.8q0s4openalex-snapshot
Data from: A curated and standardized adverse drug event resource to accelerate drug safety research
inferredcites →https://doi.org/10.7326/0003-4819-153-9-201011020-00010openalex-snapshot
Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4788499openalex-extracted
Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models
inferred← citeshttps://doi.org/10.2139/ssrn.4804332openalex-extracted
Integrated Analysis of VEGF and VEGFR Inhibitor-Induced Hypertension: Insights from Pharmacovigilance, Clinical Data, and Animal Models
inferred← citeshttps://doi.org/10.2139/ssrn.4854762openalex-extracted
Characterization of Immune Checkpoint Inhibitor-Associated Arthritis: Insights from the Two Global Pharmacovigilance Databases of FAERS and VigiBase
inferred← citeshttps://doi.org/10.1001/jamaophthalmol.2021.4778openalex-snapshot
Association Between Pentosan Polysulfate Sodium and Retinal Disorders
inferred← citeshttps://doi.org/10.1002/bcp.70182openalex-snapshot
Completeness of spontaneously reported adverse drug reactions in 4 databases
inferred← citeshttps://doi.org/10.1002/cpt.3258openalex-snapshot
Identifying Drug–Drug Interactions in Spontaneous Reports Utilizing Signal Detection and Biological Plausibility Aspects
inferred← citeshttps://doi.org/10.1002/hsr2.72865openalex-snapshot
The Real‐World Safety Profile of Immune Checkpoint Inhibitors in Melanoma: FAERS Pharmacovigilance Analysis Complemented by Randomized Trial Evidence
inferred← citeshttps://doi.org/10.1002/imo2.70014openalex-snapshot
Linking preclinical models to clinical realities: VEGF/VEGFR inhibitors and thrombotic microangiopathy in cancer therapy
inferred← citeshttps://doi.org/10.1002/pds.5609openalex-snapshot
Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions
inferred← citeshttps://doi.org/10.1002/pds.5743openalex-snapshot
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1002/pds.70043openalex-snapshot
Investigating the Safety Profile of Fast‐Track COVID ‐19 Drugs Using the FDA Adverse Event Reporting System Database: A Comparative Observational Study
inferred← citeshttps://doi.org/10.1002/pds.70216openalex-snapshot
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to RxNorm and Anatomical Therapeutic Chemical ( ATC ) Codes
inferred← citeshttps://doi.org/10.1002/phar.2920openalex-snapshot
Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
inferred← citeshttps://doi.org/10.1002/psp4.12673openalex-snapshot
Random control selection for conducting high‐throughput adverse drug events screening using large‐scale longitudinal health data
inferred← citeshttps://doi.org/10.1002/psp4.12765openalex-snapshot
Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
inferred← citeshttps://doi.org/10.1002/viw.20240113openalex-snapshot
From clinical observations to molecular insights: Decoding immune checkpoint inhibitors‐induced prostatitis
inferred← citeshttps://doi.org/10.1007/978-3-030-35231-8_46openalex-snapshot
Causality Discovery with Domain Knowledge for Drug-Drug Interactions Discovery
inferred← citeshttps://doi.org/10.1007/978-3-031-12398-6_7openalex-snapshot
Therapeutic Drug Monitoring (TDM) and Toxicological Studies in Alternative Biological Matrices
inferred← citeshttps://doi.org/10.1007/978-3-031-12700-7_35openalex-snapshot
Adverse Event Classification from Co-prescribed Drugs by Integrating Chemical, Phenotypic and Graph Embedding Features
inferred← citeshttps://doi.org/10.1007/978-3-031-20664-1_11openalex-snapshot
Requirements for Implementing Digital Health Terminology Standards in Uganda’s Electronic Medical Records-Based Health Information Systems
inferred← citeshttps://doi.org/10.1007/978-3-031-20730-3_3openalex-snapshot
Emerging Machine Learning Techniques in Predicting Adverse Drug Reactions
inferred← citeshttps://doi.org/10.1007/978-3-031-20730-3_7openalex-snapshot
Optimize and Strengthen Machine Learning Models Based on in Vitro Assays with Mechanistic Knowledge and Real-World Data
inferred← citeshttps://doi.org/10.1007/978-3-031-27173-1_22openalex-snapshot
Back to the Future: The Evolution of Pharmacovigilance in the Age of Digital Healthcare
inferred← citeshttps://doi.org/10.1007/978-3-031-55865-8_5openalex-snapshot
Relation Extraction
inferred← citeshttps://doi.org/10.1007/978-3-032-31755-1_34openalex-snapshot
CMR-VAE: A Machine Intelligence-Based Advanced Generative Framework for Interpretable Drug-Drug Interaction Prediction
inferred← citeshttps://doi.org/10.1007/978-3-319-61845-6_38openalex-snapshot
Post-marketing Drug Safety Evaluation Using Data Mining Based on FAERS
inferred← citeshttps://doi.org/10.1007/978-3-319-98779-8_20openalex-snapshot
Back to the Future: The Evolution of Pharmacovigilance in the Age of Digital Healthcare
inferred← citeshttps://doi.org/10.1007/s00204-020-02788-1openalex-snapshot
Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis
inferred← citeshttps://doi.org/10.1007/s00210-026-05028-yopenalex-snapshot
Post-marketing safety surveillance of tarlatamab: a real-world pharmacovigilance study based on the FAERS database
inferred← citeshttps://doi.org/10.1007/s00210-026-05773-0openalex-snapshot
Real-world safety profile of fezolinetant: a disproportionality analysis based on the FAERS database
inferred← citeshttps://doi.org/10.1007/s00431-026-07406-3openalex-snapshot
Safety profiles of calcineurin inhibitor-related infections in the pediatric population: a real-world pharmacovigilance analysis
inferred← citeshttps://doi.org/10.1007/s10067-026-08304-7openalex-snapshot
Post-marketing reporting patterns and disproportionality signals of mycophenolate mofetil: a pharmacovigilance study using the FAERS Database
inferred← citeshttps://doi.org/10.1007/s10462-023-10413-7openalex-snapshot
An extensive survey on the use of supervised machine learning techniques in the past two decades for prediction of drug side effects
inferred← citeshttps://doi.org/10.1007/s10557-021-07157-3openalex-snapshot
A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database
inferred← citeshttps://doi.org/10.1007/s11094-018-1895-1openalex-snapshot
Computer Prediction of Adverse Drug Effects on the Cardiovascular System
inferred← citeshttps://doi.org/10.1007/s11095-023-03516-xopenalex-snapshot
Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1007/s40256-026-00810-yopenalex-snapshot
Using Artificial Intelligence to Identify Patterns and Predictors of Adverse Drug Reactions in Cardiovascular Patients: A Comprehensive Narrative Review
inferred← citeshttps://doi.org/10.1007/s40264-018-0764-xopenalex-snapshot
Adverse Drug Events Detection in Clinical Notes by Jointly Modeling Entities and Relations Using Neural Networks
inferred← citeshttps://doi.org/10.1007/s40264-019-00872-9openalex-snapshot
Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance
inferred← citeshttps://doi.org/10.1007/s40264-020-00943-2openalex-snapshot
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
inferred← citeshttps://doi.org/10.1007/s40264-020-01022-2openalex-snapshot
Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1007/s40264-022-01190-3openalex-snapshot
Quantitative Prediction of Adverse Event Probability Due to Pharmacokinetic Interactions
inferred← citeshttps://doi.org/10.1007/s40264-022-01200-4openalex-snapshot
A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1007/s40264-023-01278-4openalex-snapshot
Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data
inferred← citeshttps://doi.org/10.1007/s40264-023-01345-wopenalex-snapshot
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach
inferred← citeshttps://doi.org/10.1007/s40264-023-01391-4openalex-snapshot
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
inferred← citeshttps://doi.org/10.1007/s40264-024-01478-6openalex-snapshot
Disproportionality Analysis and Characterisation of Medication Errors in EudraVigilance: Exploring Findings on Sexes and Age Groups
inferred← citeshttps://doi.org/10.1007/s40264-025-01545-6openalex-snapshot
A Drug Similarity-Based Bayesian Method for Early Adverse Drug Event Detection
inferred← citeshttps://doi.org/10.1016/b978-0-443-15339-6.00030-8openalex-snapshot
Centralized data sources and QSAR methods for the prediction of idiosyncratic adverse drug reaction
inferred← citeshttps://doi.org/10.1016/b978-0-443-34059-8.00003-8openalex-snapshot
AI technologies for smart pharmacology
inferred← citeshttps://doi.org/10.1016/j.aichem.2023.100011openalex-snapshot
Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity
inferred← citeshttps://doi.org/10.1016/j.curtheres.2026.100832openalex-snapshot
Integration of Clinical Pharmacokinetic Database With Compartmental Modeling and Regulatory Data Analysis
inferred← citeshttps://doi.org/10.1016/j.drudis.2019.03.003openalex-snapshot
Machine learning on adverse drug reactions for pharmacovigilance
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2019.107709openalex-snapshot
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system
inferred← citeshttps://doi.org/10.1016/j.eplepsyres.2024.107382openalex-snapshot
An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e39728openalex-snapshot
Using multiple drug similarity networks to promote adverse drug event detection
inferred← citeshttps://doi.org/10.1016/j.jaip.2025.07.018openalex-snapshot
Biologics in severe asthma: Unmasking EGPA along the way
inferred← citeshttps://doi.org/10.1016/j.jbi.2016.12.005openalex-snapshot
Accuracy of an automated knowledge base for identifying drug adverse reactions
inferred← citeshttps://doi.org/10.1016/j.jbi.2017.12.009openalex-snapshot
Standardization of immunotherapy adverse events in patient information leaflets and development of an interface terminology for outpatients’ monitoring
inferred← citeshttps://doi.org/10.1016/j.jbi.2018.07.001openalex-snapshot
From narrative descriptions to MedDRA: automagically encoding adverse drug reactions
inferred← citeshttps://doi.org/10.1016/j.jbi.2019.103119openalex-snapshot
ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model
inferred← citeshttps://doi.org/10.1016/j.jbi.2020.103587openalex-snapshot
Towards a goal-oriented methodology for clinical-guideline-based management recommendations for patients with multimorbidity: GoCom and its preliminary evaluation
inferred← citeshttps://doi.org/10.1016/j.jbi.2021.103833openalex-snapshot
Augmenting aer2vec: Enriching distributed representations of adverse event report data with orthographic and lexical information
inferred← citeshttps://doi.org/10.1016/j.jbi.2023.104395openalex-snapshot
A community-of-practice-based evaluation methodology for knowledge intensive computational methods and its application to multimorbidity decision support
inferred← citeshttps://doi.org/10.1016/j.jbi.2024.104639openalex-snapshot
Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records
inferred← citeshttps://doi.org/10.1016/j.jcjq.2026.07.008openalex-snapshot
Using SMS Texting for Adverse Drug Reaction Surveillance: Evaluation of New Medication Prescriptions in Primary Care
inferred← citeshttps://doi.org/10.1016/j.jphs.2022.10.006openalex-snapshot
Acetaminophen improves tardive akathisia induced by dopamine D2 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.medj.2025.100642openalex-snapshot
OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models
inferred← citeshttps://doi.org/10.1016/j.numecd.2018.02.014openalex-snapshot
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
inferred← citeshttps://doi.org/10.1016/j.slasd.2022.12.003openalex-snapshot
Using chemical and biological data to predict drug toxicity
inferred← citeshttps://doi.org/10.1016/j.tips.2019.07.005openalex-snapshot
Artificial Intelligence for Drug Toxicity and Safety
inferred← citeshttps://doi.org/10.1016/j.yebeh.2021.107832openalex-snapshot
Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1016/j.yjbinx.2020.100085openalex-snapshot
WITHDRAWN: Towards a goal-oriented methodology for clinical-guideline-based management recommendations for patients with multimorbidity: GoCom and its preliminary evaluation
inferred← citeshttps://doi.org/10.1017/s0714980823000806openalex-snapshot
Drug and Natural Health Product Data Collection and Curation in the Canadian Longitudinal Study on Aging
inferred← citeshttps://doi.org/10.1021/acs.chemrestox.0c00294openalex-snapshot
Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports
inferred← citeshttps://doi.org/10.1021/acs.chemrestox.0c00347openalex-snapshot
Quantitative Structure–Activity Relationship (QSAR) Model for the Severity Prediction of Drug-Induced Rhabdomyolysis by Using Random Forest
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b00683openalex-snapshot
ROBOKOP KG and KGB: Integrated Knowledge Graphs from Federated Sources
inferred← citeshttps://doi.org/10.1038/s41398-025-03456-7openalex-snapshot
Pharmacologic and genetic evidence converge on mechanisms of psychotic illness
inferred← citeshttps://doi.org/10.1038/s41467-020-18305-yopenalex-snapshot
Predicting the frequencies of drug side effects
inferred← citeshttps://doi.org/10.1038/s41467-023-40064-9openalex-snapshot
A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs
inferred← citeshttps://doi.org/10.1038/s41540-022-00221-0openalex-snapshot
Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects
inferred← citeshttps://doi.org/10.1038/s41597-022-01159-yopenalex-snapshot
A reference set of clinically relevant adverse drug-drug interactions
inferred← citeshttps://doi.org/10.1038/s41597-022-01510-3openalex-snapshot
The heterogeneous pharmacological medical biochemical network PharMeBINet
inferred← citeshttps://doi.org/10.1038/s41597-025-04718-1openalex-snapshot
An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results
inferred← citeshttps://doi.org/10.1038/s41598-018-19979-7openalex-snapshot
An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence
inferred← citeshttps://doi.org/10.1038/s41598-020-80569-7openalex-snapshot
Adverse outcomes associated with the treatment of Toxoplasma infections
inferred← citeshttps://doi.org/10.1038/s41598-021-98325-wopenalex-snapshot
Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database
inferred← citeshttps://doi.org/10.1038/s41598-023-51004-4openalex-snapshot
Broadening the capture of natural products mentioned in FAERS using fuzzy string-matching and a Siamese neural network
inferred← citeshttps://doi.org/10.1038/s41598-024-69614-xopenalex-snapshot
Long-term hepatobiliary disorder associated with trastuzumab emtansine pharmacovigilance study using the FDA Adverse Event Reporting System database
inferred← citeshttps://doi.org/10.1038/s41598-024-74505-2openalex-snapshot
Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data
inferred← citeshttps://doi.org/10.1038/s43588-024-00748-8openalex-snapshot
Leveraging pharmacovigilance data to predict population-scale toxicity profiles of checkpoint inhibitor immunotherapy
inferred← citeshttps://doi.org/10.1038/s43856-025-01169-yopenalex-snapshot
Insights from pharmacovigilance databases, clinical cohorts and preclinical models into VEGF(R) inhibitor-induced arthritis in cancer
inferred← citeshttps://doi.org/10.1055/s-0037-1606475openalex-snapshot
Contents IMIA Yearbook of Medical Informatics 2017
inferred← citeshttps://doi.org/10.1055/s-0037-1606496openalex-snapshot
Knowledge Representation and Management, It’s Time to Integrate!
inferred← citeshttps://doi.org/10.1055/s-0037-1606521openalex-snapshot
Best Paper Selection
inferred← citeshttps://doi.org/10.1055/s-0039-1677908openalex-snapshot
AI in Health: State of the Art, Challenges, and Future Directions
inferred← citeshttps://doi.org/10.1080/02713683.2023.2219041openalex-snapshot
The Association Between Taxane Use and Lacrimal Disorders
inferred← citeshttps://doi.org/10.1080/14740338.2022.1993820openalex-snapshot
Improving the data quality of spontaneous ADR reports: a practical example from Malta
inferred← citeshttps://doi.org/10.1080/14740338.2023.2277801openalex-snapshot
A pharmacovigilance study on drug-induced liver injury associated with antibody-drug conjugates (ADCs) based on the food and drug administration adverse event reporting system
inferred← citeshttps://doi.org/10.1080/14740338.2024.2309223openalex-snapshot
Utilizing temporal pattern of adverse event reports to identify potential late-onset adverse events
inferred← citeshttps://doi.org/10.1080/14740338.2024.2341813openalex-snapshot
Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database
inferred← citeshttps://doi.org/10.1080/14740338.2024.2368817openalex-snapshot
The evolving role of disproportionality analysis in pharmacovigilance
inferred← citeshttps://doi.org/10.1080/14740338.2024.2387314openalex-snapshot
Signal of dementia with proton pump inhibitor after minimizing competition bias: an updated disproportionality analysis
inferred← citeshttps://doi.org/10.1080/14740338.2024.2416256openalex-snapshot
Combined nephrotoxicity of Polymyxins and Vancomycin: a study on adverse event reporting for monotherapy versus combinations using the FDA adverse event reporting system (FAERS)
inferred← citeshttps://doi.org/10.1080/14740338.2025.2487158openalex-snapshot
Adverse event signal analysis of type Ib MET tyrosine kinase inhibitors based on food and drug administration adverse event reporting system
inferred← citeshttps://doi.org/10.1080/14740338.2025.2490837openalex-snapshot
Analysis of adverse events induced by fluconazole based on FAERS database
inferred← citeshttps://doi.org/10.1080/14740338.2025.2490847openalex-snapshot
Dementia-related adverse events associated with direct oral anticoagulants use: a real-world, pharmacovigilance study based on the FAERS database
inferred← citeshttps://doi.org/10.1080/17425255.2023.2299337openalex-snapshot
In-silico approaches to assessing multiple high-level drug-drug and drug-disease adverse drug effects
inferred← citeshttps://doi.org/10.1080/17476348.2023.2294927openalex-snapshot
High risks adverse events associated with usage of aspirin in chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1093/bib/bbab239openalex-snapshot
A novel graph attention model for predicting frequencies of drug–side effects from multi-view data
inferred← citeshttps://doi.org/10.1093/bib/bbab586openalex-snapshot
DSGAT: predicting frequencies of drug side effects by graph attention networks
inferred← citeshttps://doi.org/10.1093/bib/bbx099openalex-snapshot
Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models
inferred← citeshttps://doi.org/10.1093/bib/bbz140openalex-snapshot
A survey on adverse drug reaction studies: data, tasks and machine learning methods
inferred← citeshttps://doi.org/10.1093/database/baab068openalex-snapshot
Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
inferred← citeshttps://doi.org/10.1093/jamiaopen/ooag094openalex-snapshot
irAE.AI: AI-powered exploration of real-world immune-related adverse events
inferred← citeshttps://doi.org/10.1097/iop.0000000000002668openalex-snapshot
Teprotumumab-Related Hearing Loss: A Large-Scale Analysis and Review of Voluntarily Reported Patient Complaints to the Food and Drug Administration (FDA)
inferred← citeshttps://doi.org/10.1097/j.jcrs.0000000000001738openalex-snapshot
Primary suspect drugs of cataracts in pediatric patients: FDA adverse events reporting database analysis
inferred← citeshttps://doi.org/10.1101/2020.06.12.135939openalex-snapshot
Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and post-marketing reports
inferred← citeshttps://doi.org/10.1101/2022.01.07.22268907openalex-snapshot
A Computational Framework for Identifying Age Risks in Drug-Adverse Event Pairs
inferred← citeshttps://doi.org/10.1101/2023.05.31.23290792openalex-snapshot
An Early Adverse Drug Event Detection Approach with False Discovery Rate Control
inferred← citeshttps://doi.org/10.1101/2024.03.22.24304724openalex-snapshot
OnSIDES (ON-label SIDE effectS resource) Database : Extracting Adverse Drug Events from Drug Labels using Natural Language Processing Models
inferred← citeshttps://doi.org/10.1101/2025.03.05.25323441openalex-snapshot
Demographics, Overlap, and Latency of Severe Cutaneous Adverse Reactions in an FDA Database
inferred← citeshttps://doi.org/10.1101/243998openalex-snapshot
Rapid Identification and Validation of Novel Rheumatoid Arthritis Drug Treatments using an Integrative Bioinformatics Platform
inferred← citeshttps://doi.org/10.1101/380832openalex-snapshot
Predicting Negative Control Drugs to Support Research in Drug Safety
inferred← citeshttps://doi.org/10.1101/780544openalex-snapshot
aer2vec : Distributed Representations of Adverse Event Reporting System Data as a Means to Identify Drug/Side-Effect Associations
inferred← citeshttps://doi.org/10.1109/ai-si66213.2025.11341191openalex-snapshot
Deepmyco: Large Language Models for Scaling Mycoremediation
inferred← citeshttps://doi.org/10.1109/bibm.2018.8621427openalex-snapshot
Comparing adverse effects of Hepatitis C drugs using FAERS data
inferred← citeshttps://doi.org/10.1109/cscwd49262.2021.9437783openalex-snapshot
Discovering Adverse Drug Reactions from Twitter: A Sentiment Analysis Perspective
inferred← citeshttps://doi.org/10.1109/iccccm61016.2024.11039905openalex-snapshot
Machine Learning Classification Approach for Empirical Analysis of Therapeutic Drug Monitoring
inferred← citeshttps://doi.org/10.1109/icdacai59742.2023.00158openalex-snapshot
A Neural Collaborative Filtering Model for Adverse Drug Reaction Prediction
inferred← citeshttps://doi.org/10.1109/tce.2025.3572452openalex-snapshot
An Event-Aware Dual Representation Model With Mixture-of-Experts for Serious Adverse Events Prediction in Clinical Trials
inferred← citeshttps://doi.org/10.1109/urtc45901.2018.9244814openalex-snapshot
Drug-Drug Interaction Signal Detection from Drug Safety Reports
inferred← citeshttps://doi.org/10.1111/bcp.15336openalex-snapshot
Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1111/cts.13505openalex-snapshot
An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021
inferred← citeshttps://doi.org/10.1111/cts.13871openalex-snapshot
Using electronic health records for clinical pharmacology research: Challenges and considerations
inferred← citeshttps://doi.org/10.1117/12.3003844openalex-snapshot
Prediction of frequencies of drug side effects using social recommendation algorithm based on multi-feature fusion
inferred← citeshttps://doi.org/10.1139/cjpp-2024-0078openalex-snapshot
Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database
inferred← citeshttps://doi.org/10.1142/9789813235533_0025openalex-snapshot
Identifying natural health product and dietary supplement information within adverse event reporting systems
inferred← citeshttps://doi.org/10.1142/s0219649224501004openalex-snapshot
A Knowledge Graph Embedding-based Approach to Predict the Adverse Drug Reactions using a Convolutional Neural Network
inferred← citeshttps://doi.org/10.1155/2020/1747413openalex-snapshot
A Modified Skip-Gram Algorithm for Extracting Drug-Drug Interactions from AERS Reports
inferred← citeshttps://doi.org/10.1155/jcpt/8979418openalex-snapshot
Identifying Cardiac Adverse Event Signals for Natural Products Using Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-23-0914openalex-snapshot
A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions
inferred← citeshttps://doi.org/10.1172/jci.insight.145632openalex-snapshot
Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia
inferred← citeshttps://doi.org/10.1177/00368504251387821openalex-snapshot
Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database
inferred← citeshttps://doi.org/10.1177/10600280221148031openalex-snapshot
Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)
inferred← citeshttps://doi.org/10.1177/1177932220921350openalex-snapshot
Identifying Herbal Adverse Events From Spontaneous Reporting Systems Using Taxonomic Name Resolution Approach
inferred← citeshttps://doi.org/10.1177/1533317519899546openalex-snapshot
Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS
inferred← citeshttps://doi.org/10.1177/20420986231181334openalex-snapshot
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study
inferred← citeshttps://doi.org/10.1177/20420986261462682openalex-snapshot
Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database
inferred← citeshttps://doi.org/10.1177/2168479019854339openalex-snapshot
What Could the Future of Safety Monitoring Look Like?
inferred← citeshttps://doi.org/10.1177/27683605261456017openalex-snapshot
A Retrospective Pharmacovigilance Disproportionality Analysis of Possible Nephrotoxicity and Natural Products Using Data from the FDA Adverse Event Reporting System
inferred← citeshttps://doi.org/10.1186/s12874-023-01885-wopenalex-snapshot
Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions
inferred← citeshttps://doi.org/10.1186/s12885-025-14546-6openalex-snapshot
Comparative safety of nivolumab plus ipilimumab versus nivolumab plus relatlimab in advanced melanoma: a pharmacovigilance study based on the FDA adverse event reporting system (FAERS)
inferred← citeshttps://doi.org/10.1186/s12911-019-0860-6openalex-snapshot
Comparing drug safety of hepatitis C therapies using post-market data
inferred← citeshttps://doi.org/10.1186/s12911-019-0999-1openalex-snapshot
Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
inferred← citeshttps://doi.org/10.1186/s12911-021-01520-yopenalex-snapshot
An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources
inferred← citeshttps://doi.org/10.1186/s12911-022-01869-8openalex-snapshot
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
inferred← citeshttps://doi.org/10.1186/s13326-017-0115-3openalex-snapshot
Large-scale adverse effects related to treatment evidence standardization (LAERTES): an open scalable system for linking pharmacovigilance evidence sources with clinical data
inferred← citeshttps://doi.org/10.1186/s13326-017-0137-xopenalex-snapshot
Discovering associations between adverse drug events using pattern structures and ontologies
inferred← citeshttps://doi.org/10.1186/s40360-023-00657-yopenalex-snapshot
Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1186/s40360-024-00782-2openalex-snapshot
Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1186/s40780-024-00388-0openalex-snapshot
Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1192/j.eurpsy.2024.1803openalex-snapshot
Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
inferred← citeshttps://doi.org/10.1248/bpb.b19-00929openalex-snapshot
Drug Repositioning and Target Finding Based on Clinical Evidence
inferred← citeshttps://doi.org/10.1248/bpb.b22-00861openalex-snapshot
Inhibitors of the Mechanistic Target of Rapamycin Can Ameliorate Bortezomib-Induced Peripheral Neuropathy
inferred← citeshttps://doi.org/10.12677/pi.2025.145042openalex-snapshot
Bibliometric Analysis of Research Status on Data Mining of Drug Adverse Events Based on FAERS
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1006851openalex-snapshot
Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions
inferred← citeshttps://doi.org/10.1371/journal.pone.0231252openalex-snapshot
A compound attributes-based predictive model for drug induced liver injury in humans
inferred← citeshttps://doi.org/10.1371/journal.pone.0316573openalex-snapshot
Data mining of adverse drug event signals with Nirmatrelvir/Ritonavir from FAERS
inferred← citeshttps://doi.org/10.14569/ijacsa.2022.0130924openalex-snapshot
A Comprehensive Review and Application of Interpretable Deep Learning Model for ADR Prediction
inferred← citeshttps://doi.org/10.18653/v1/2023.findings-emnlp.896openalex-snapshot
BioDEX: Large-Scale Biomedical Adverse Drug Event Extraction for Real-World Pharmacovigilance
inferred← citeshttps://doi.org/10.21203/rs.3.rs-16986/v1openalex-snapshot
Neoadjuvant Laparoscopic HIPEC combined with Neoadjuvant Chemotherapy followed by Surgery plus intraoperative HIPEC for Advanced Gastric Cancer at risk of Peritoneal Carcinomatosis: feasibility and safety assessment from retrospective case control study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3085472/v1openalex-snapshot
Drug and natural health product data collection and curation in the Canadian Longitudinal Study on Aging (CLSA)
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4088785/v1openalex-snapshot
Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab: A Case Series from the FDA Adverse Event Reporting System (FAERS) Database
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4864640/v1openalex-snapshot
SDV-HGNN: similarity-based dual view heterogeneous graph neural network method for drug adverse side effect prediction
inferred← citeshttps://doi.org/10.21203/rs.3.rs-8374189/v1openalex-snapshot
Safety signals of amide local anesthetics in dentistry: a real-world data analysis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-9454760/v1openalex-snapshot
The Global Compatibility Index (GCI): A Variance-Weighted Pharmacogenomic Scoring System Demonstrates Near-Perfect Cross-Mode Consistency (ICC = 0.994) and Improves Warfarin Dose Prediction Over the CPIC Algorithm in 5,475 Patients Across Four Continents, with Multi-Drug Validation Across 10…
inferred← citeshttps://doi.org/10.2139/ssrn.5390672openalex-snapshot
Enhancing Safety Signaling: Integrating Clinical Trials and Post-Marketing Adverse Event Reports
inferred← citeshttps://doi.org/10.21608/bjas.2024.274193.1343openalex-snapshot
A comprehensive survey explores Drug-Drug interaction prediction using Machine-Learning techniques
inferred← citeshttps://doi.org/10.2196/14083openalex-snapshot
Developing a Standardization Algorithm for Categorical Laboratory Tests for Clinical Big Data Research: Retrospective Study
inferred← citeshttps://doi.org/10.2196/17353openalex-snapshot
Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study
inferred← citeshttps://doi.org/10.2196/18417openalex-snapshot
Extraction of Information Related to Drug Safety Surveillance From Electronic Health Record Notes: Joint Modeling of Entities and Relations Using Knowledge-Aware Neural Attentive Models
inferred← citeshttps://doi.org/10.2196/preprints.108514openalex-snapshot
Cardiotoxicity Associated With Quinolone Antibiotics: A Cross-National Real-World Data-Mining Study Using FAERS and JADER (Preprint)
inferred← citeshttps://doi.org/10.2196/preprints.19979openalex-snapshot
A Data Driven Approach to Profile Potential SARS-CoV-2 Drug Interactions Using TylerADE (Preprint)
inferred← citeshttps://doi.org/10.2196/publichealth.9361openalex-snapshot
Clinical Relation Extraction Toward Drug Safety Surveillance Using Electronic Health Record Narratives: Classical Learning Versus Deep Learning
inferred← citeshttps://doi.org/10.26300/z6n9-xd36openalex-snapshot
Exploring the Potential of Direct-To-Consumer Genomic Test Data for Predicting Adverse Drug Events
inferred← citeshttps://doi.org/10.31083/ap44501openalex-snapshot
Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.31083/ijp50806openalex-snapshot
Skin Adverse Events Linked to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis Using FAERS and Drug–Gene Interaction Network Analyses
inferred← citeshttps://doi.org/10.3233/shti220090openalex-snapshot
Detecting Drug-Drug Interactions in COVID-19 Patients
inferred← citeshttps://doi.org/10.3389/fbinf.2023.1328613openalex-snapshot
RxNorm for drug name normalization: a case study of prescription opioids in the FDA adverse events reporting system
inferred← citeshttps://doi.org/10.3389/fcvm.2026.1715192openalex-snapshot
Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system database
inferred← citeshttps://doi.org/10.3389/fddsv.2021.768792openalex-snapshot
Deep Learning Prediction of Adverse Drug Reactions in Drug Discovery Using Open TG–GATEs and FAERS Databases
inferred← citeshttps://doi.org/10.3389/fgene.2018.00412openalex-snapshot
Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1084960openalex-snapshot
Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1396752openalex-snapshot
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1488853openalex-snapshot
Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1707211openalex-snapshot
Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy: roles of underlying diseases and immunomodulatory therapies in FAERS
inferred← citeshttps://doi.org/10.3389/fmed.2026.1799557openalex-snapshot
Neuropsychiatric adverse events of SGLT2 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database
inferred← citeshttps://doi.org/10.3389/fonc.2022.954468openalex-snapshot
Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study
inferred← citeshttps://doi.org/10.3389/fonc.2026.1788532openalex-snapshot
Respiratory adverse events associated with PD-1/PD-L1 inhibitors: an analysis based on the FDA adverse event reporting system
showing the first 200 of 243 · page through all 243
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.